Items where authors include "Brend, T"

Article

Struve, N, Binder, ZA, Stead, LF orcid.org/0000-0002-9550-4150 et al. (19 more authors) (2020) EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastoma. Oncogene, 39 (15). pp. 3041-3055. ISSN 0950-9232

Chambers, JS, Brend, T and Rabbitts, TH (2019) Cancer cell killing by target antigen engagement with engineered complementary intracellular antibody single domains fused to pro-caspase3. Scientific reports, 9 (1). ARTN: 8553. ISSN 2045-2322

Haynes, HR, Scott, HL, Killick-Cole, CL et al. (18 more authors) (2019) shRNA-mediated PPAR alpha knockdown in human glioma stem cells reduces in vitro proliferation and inhibits orthotopic xenograft tumour growth. Journal of Pathology, 247 (4). pp. 422-434. ISSN 0022-3417

Guillotin, D, Austin, P, Begum, R et al. (6 more authors) (2017) Drug-repositioning screens identify Triamterene as a selective drug for the treatment of DNA Mismatch Repair deficient cells. Clinical Cancer Research, 23 (11). pp. 2869-2879. ISSN 1078-0432

King, HO, Brend, T, Payne, HL et al. (8 more authors) (2017) RAD51 Is a Selective DNA Repair Target to Radiosensitize Glioma Stem Cells. Stem Cell Reports, 8 (1). pp. 125-139.

Ruggero, K, Al-Assar, O, Chambers, JS et al. (3 more authors) (2016) LMO2 and IL2RG synergize in thymocytes to mimic the evolution of SCID-X1 gene therapy-associated T-cell leukaemia. Leukemia, 30 (9). pp. 1959-1962. ISSN 0887-6924

Conference or Workshop Item

Struve, N, Binder, ZA, Stead, LF orcid.org/0000-0002-9550-4150 et al. (18 more authors) (2019) CBMT-16: EGFRvIII Expression Confers Chemosensitivity by Increasing DNA Mismatch Repair Protein Expression and Replication Stress. In: 24th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology, 22-24 Nov 2019, Phoenix, Arizona, USA.